- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Adhesive anti-fibrotic interfaces on diverse organs ; volume:630 ; number:8016 ; day:22 ; month:5 ; year:2024 ; pages:360-367 ; date:6.2024
Nature; 630, Heft 8016 (22.5.2024), 360-367, 6.2024
- Urheber
-
Wu, Jingjing
Deng, Jue
Theocharidis, Georgios
Sarrafian, Tiffany L.
Griffiths, Leigh G.
Bronson, Roderick T.
Veves, Aristidis
Chen, Jianzhu
Yuk, Hyunwoo
Zhao, Xuanhe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41586-024-07426-9
- URN
-
urn:nbn:de:101:1-2410090821237.739464266141
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:34 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wu, Jingjing
- Deng, Jue
- Theocharidis, Georgios
- Sarrafian, Tiffany L.
- Griffiths, Leigh G.
- Bronson, Roderick T.
- Veves, Aristidis
- Chen, Jianzhu
- Yuk, Hyunwoo
- Zhao, Xuanhe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Hepatoprotective and Anti-fibrotic Agents: Its Time to Take the Next Step
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Hepatoprotective and Anti-fibrotic Agents: Its Time to Take the Next Step
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles
Identification and functional characterization of anti-fibrotic natural compounds in vitro
Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Hepatoprotective and Anti-fibrotic Agents: Its Time to Take the Next Step